Sensus Healthcare Management
Management criteria checks 3/4
Sensus Healthcare's CEO is Joe Sardano, appointed in Jun 2010, has a tenure of 13.92 years. total yearly compensation is $754.43K, comprised of 53% salary and 47% bonuses, including company stock and options. directly owns 7.17% of the company’s shares, worth $4.42M. The average tenure of the management team and the board of directors is 2.8 years and 7.6 years respectively.
Key information
Joe Sardano
Chief executive officer
US$754.4k
Total compensation
| CEO salary percentage | 53.0% |
| CEO tenure | 13.9yrs |
| CEO ownership | 7.2% |
| Management average tenure | 2.8yrs |
| Board average tenure | 7.6yrs |
Recent management updates
Recent updates
Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk
Apr 16
Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 11There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital
Oct 17Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger
Jul 04Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop
Mar 14Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?
Mar 06Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger
Oct 11Sensus Healthcare Q2 GAAP EPS, revenue beats
Aug 04Sensus Healthcare: A Buy In Honor Of Skin Cancer Awareness Month
May 21Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts
May 11Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist
Apr 29Sensus Healthcare's (NASDAQ:SRTS) Earnings Are Of Questionable Quality
Apr 01Are Investors Undervaluing Sensus Healthcare, Inc. (NASDAQ:SRTS) By 31%?
Dec 17We Discuss Why Sensus Healthcare, Inc.'s (NASDAQ:SRTS) CEO Compensation May Be Closely Reviewed
May 30Sensus Healthcare: Likely Post-Pandemic Sales Recovery Can Boost Share Price
Apr 26Analysts Expect Breakeven For Sensus Healthcare, Inc. (NASDAQ:SRTS) Before Long
Apr 19Sensus Healthcare's (NASDAQ:SRTS) Stock Price Has Reduced 30% In The Past Three Years
Feb 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | US$485k |
| Sep 30 2023 | n/a | n/a | -US$896k |
| Jun 30 2023 | n/a | n/a | US$2m |
| Mar 31 2023 | n/a | n/a | US$6m |
| Dec 31 2022 | US$754k | US$400k | US$24m |
| Sep 30 2022 | n/a | n/a | US$27m |
| Jun 30 2022 | n/a | n/a | US$25m |
| Mar 31 2022 | n/a | n/a | US$21m |
| Dec 31 2021 | US$628k | US$375k | US$4m |
| Sep 30 2021 | n/a | n/a | -US$181k |
| Jun 30 2021 | n/a | n/a | -US$2m |
| Mar 31 2021 | n/a | n/a | -US$4m |
| Dec 31 2020 | US$510k | US$375k | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$7m |
| Jun 30 2020 | n/a | n/a | -US$6m |
| Mar 31 2020 | n/a | n/a | -US$3m |
| Dec 31 2019 | US$467k | US$375k | -US$2m |
| Sep 30 2019 | n/a | n/a | -US$3m |
| Jun 30 2019 | n/a | n/a | -US$2m |
| Mar 31 2019 | n/a | n/a | -US$3m |
| Dec 31 2018 | US$538k | US$360k | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$3m |
| Jun 30 2018 | n/a | n/a | -US$3m |
| Mar 31 2018 | n/a | n/a | -US$3m |
| Dec 31 2017 | US$490k | US$324k | -US$4m |
Compensation vs Market: Joe's total compensation ($USD754.43K) is about average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Joe's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Joe Sardano (70 yo)
13.9yrs
Tenure
US$754,428
Compensation
Mr. Joseph C. Sardano, also known as Joe, serves as Director at BioFlorida Inc since August 2021. He Co-Founded Sensus Healthcare, Inc. in 2010 and has been its Chairman of the Board, Chief Executive Offic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.9yrs | US$754.43k | 7.17% $ 4.4m | |
| President | 7.3yrs | US$404.74k | 0.48% $ 296.2k | |
| Chief Financial Officer | 4.3yrs | US$439.14k | 0.27% $ 166.1k | |
| Chief Operating Officer | 1.3yrs | no data | 0.11% $ 64.9k | |
| Chief Technology Officer | 1.3yrs | no data | 0.061% $ 37.6k | |
| Vice President of Marketing | 1.3yrs | no data | no data |
2.8yrs
Average Tenure
45yo
Average Age
Experienced Management: SRTS's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.9yrs | US$754.43k | 7.17% $ 4.4m | |
| President | less than a year | US$404.74k | 0.48% $ 296.2k | |
| Independent Director | 7.8yrs | US$60.00k | 0.28% $ 174.7k | |
| Independent Director | 12.3yrs | US$60.00k | 0.49% $ 300.6k | |
| Member of Medical Advisory Board | 7.3yrs | no data | no data | |
| Independent Director | 12.3yrs | US$60.00k | 0.88% $ 539.8k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | 7.3yrs | no data | no data | |
| Member of Medical Advisory Board | 7.3yrs | no data | no data | |
| Independent Director | 8.6yrs | US$60.00k | 0.061% $ 37.6k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | 6.5yrs | no data | no data |
7.6yrs
Average Tenure
70yo
Average Age
Experienced Board: SRTS's board of directors are considered experienced (7.6 years average tenure).